16,000,000 Shares of Common
Stock
(Par Value $0.01 Per Share)
BioMed Realty Trust, Inc.
(a Maryland Corporation)
RAYMOND JAMES
& ASSOCIATES, INC.
KEYBANC CAPITAL MARKETS INC.
MORGAN STANLEY & CO. INCORPORATED
UBS SECURITIES LLC
WACHOVIA CAPITAL MARKETS, LLC
CREDIT SUISSE SECURITIES (USA) LLC
As Representatives of the Several Underwriters listed on
Schedule I hereto
c/o Raymond James &Associates, Inc.
880 Carillon Parkway
St. Petersburg, Florida 33716
BioMed Realty
Trust, Inc., a Maryland corporation (the “ Company
”), and BioMed Realty, L.P., a Maryland limited partnership
(the “ Operating Partnership ” and together with
the Company, the “ Transaction Entities ”), each
confirms its agreement with Raymond James & Associates, Inc.
(“ Raymond James ”), KeyBanc Capital Markets
Inc. (“ KeyBanc ”), Morgan Stanley & Co.
Incorporated (“ Morgan Stanley ”), UBS
Securities LLC (“ UBS ”), Wachovia Capital
Markets, LLC (“ Wachovia ”) and Credit Suisse
Securities (USA) LLC (“ Credit Suisse ”)
and each of the other underwriters named in Schedule I
hereto (the “ Underwriters ”) for whom Raymond
James, KeyBanc, Morgan Stanley, UBS, Wachovia and Credit Suisse are
acting as representatives (the “ Representatives
”) with respect to the issuance and sale by the Company and
the purchase by the Underwriters, acting severally and not jointly,
of 16,000,000 shares (the “ Firm Securities ”)
of the Company’s common stock, par value $0.01 per share (the
“ Common Stock ”), and with respect to the grant
by the Company to the Underwriters, acting severally and not
jointly, of an option to purchase an aggregate of not more than
2,400,000 additional shares of Common Stock (the “
Optional Securities ”), subject to the terms and
conditions set forth below. The Firm Securities and the Optional
Securities are herein collectively called the “ Offered
Securities .” This agreement by and among the Company,
the Operating Partnership and the Underwriters shall be referred to
as this “ Agreement .”
The Company will
contribute the net proceeds from each sale of the Offered
Securities to the Operating Partnership and, in exchange therefor,
at the Closing Date (as defined herein) of each such sale, the
Operating Partnership will issue to the Company units of limited
partnership interest in the Operating Partnership (“ OP
Units ”).
The Company has
filed with the Securities and Exchange Commission (the “
Commission ”) an automatic shelf registration
statement on Form S-3 (No. 333-137376), including the
related base prospectus, covering the registration of the Offered
Securities under the Securities Act of 1933, as amended (the
“ Act ”). Such registration statement became
effective upon filing pursuant to Rule 462(e) of the rules and
regulations of the Commission under the Act (the “
Securities Act Regulations ”) on September 15,
2006. Promptly after execution and delivery of this Agreement, the
Company will prepare and file a prospectus supplement in accordance
with the provisions of Rule 430B of the Securities Act Regulations
(“ Rule 430B ”) and paragraph (b) of
Rule 424 (“ Rule 424(b) ”) of the
Securities Act Regulations. Any information included in such
prospectus supplement that was omitted from such registration
statement at the time it became effective but that is deemed to be
part of and included in such registration statement pursuant to
Rule 430B is referred to as “ Rule 430B
Information .” Each base prospectus and prospectus
supplement used in connection with the offering of the Offered
Securities that omitted Rule 430B Information is hereinafter
collectively called a “preliminary
prospectus.”
Such registration
statement, at any given time, including the amendments thereto to
such time, the exhibits and any schedules thereto at such time, the
documents incorporated by reference thereto pursuant to
Item 12 of Form S-3 under the Act at such time and the
documents otherwise deemed to be a part thereof or included therein
by the Securities Act Regulations, and the Rule 430B Information is
herein called the “ Registration Statement .”
The Registration Statement at the time it originally became
effective is herein called the “ Original Registration
Statement .” The base prospectus and the final prospectus
supplement in the form first furnished (electronically or
otherwise) to the Underwriters for use in connection with the
offering of the Offered Securities (whether to meet the requests of
purchasers pursuant to Rule 173 under the Act or otherwise),
including the documents incorporated by reference therein pursuant
to Item 12 of Form S-3 under the Act at the time of execution
of this Agreement, is herein called the “ Prospectus
.” The Commission has not issued any order preventing or
suspending the use of any preliminary prospectus.
For purposes of
this Agreement (other than in connection with any opinion given by
counsel in Section 5 hereof, which hereby expressly
excludes any copy filed via Electronic Data Gathering, Analysis and
Retrieval System (“ EDGAR ”)), all references to
the “ Original Registration Statement ,” “
Registration Statement, ” the “
Prospectus, ” any “ preliminary
prospectus, ” or any amendment or supplement to any of
the foregoing shall be deemed to include the copy filed with the
Commission pursuant to EDGAR.
All references in
this Agreement to financial statements and schedules and other
information which is “contained,”
“included” or “stated” in the Registration
Statement, any preliminary prospectus, the Prospectus or the
General Disclosure Package (or other references of like import)
shall be deemed to mean and include all such financial statements
and schedules and other information which is incorporated by
reference in or otherwise deemed by Securities Act Regulations to
be a part of or included in the Registration Statement, any
preliminary prospectus or the Prospectus, as the case may be; and
all references in this Agreement to amendments or supplements to
the Registration Statement, any preliminary prospectus or the
Prospectus shall be
- 2 -
deemed to mean
and include the filing of any document under the Securities
Exchange Act of 1934, as amended (the “ Exchange Act
”) which is incorporated by reference in or otherwise deemed
by Securities Act Regulations to be a part of or included in the
Registration Statement, such preliminary prospectus or the
Prospectus, as the case may be.
1.
Representations and Warranties of the Transaction
Entities . Each of the Transaction Entities, jointly and
severally, represents and warrants to, and agrees with, the several
Underwriters as of the date hereof, the Applicable Time referred to
in Section 1.A hereof, and as of each respective Closing Date
referred to in Section 2 hereof, that:
A. Status
as a Well-Known Seasoned Issuer; Registration Statement Effective;
Conform to Act; No Misleading Statements; Conformity with EDGAR
filings.
(1)
(A) At the time of filing the Original Registration Statement,
(B) at the time the Company or any person acting on its behalf
(within the meaning, for this clause only, of Rule 163(c) of the
Securities Act Regulations) made any offer relating to the Offered
Securities in reliance on the exemption of Rule 163 of the
Securities Act Regulations ( “Rule 163” )
and (C) at the date hereof, the Company (x) was and is a
“well-known seasoned issuer” as defined in Rule 405 of
the Securities Act Regulations (“ Rule 405
”) and (y) was not and is not an “ineligible
issuer,” as defined in Rule 405. The Registration
Statement is an “automatic shelf registration
statement,” as defined in Rule 405, and the Offered
Securities, since their registration on the Registration Statement,
have been and remain eligible for registration by the Company on a
Rule 405 “automatic shelf registration statement”.
The Company has not received from the Commission any notice
pursuant to Rule 401(g)(2) of the Securities Act Regulations
objecting to the use of the automatic shelf registration statement
form.
At
the time of filing the Original Registration Statement, at the
earliest time thereafter that the Company or another offering
participant made a bona fide offer (within the meaning of
Rule 164(h)(2) of the Securities Act Regulations) of the
Offered Securities and at the date hereof, the Company was not and
is not an “ineligible issuer,” as defined in
Rule 405.
(2)
The Original Registration Statement became effective upon filing
under Rule 462(e) of the Securities Act Regulations (“
Rule 462(e) ”) on September 15, 2006, and
any post-effective amendment thereto also became effective upon
filing under Rule 462(e).
Any
offer that is a written communication relating to the Offered
Securities made prior to the filing of the Original Registration
Statement by the Company or any person acting on its behalf (within
the meaning, for this paragraph only, of Rule 163(c) of the
Securities Act Regulations) has been filed with the Commission in
accordance with the exemption provided by Rule 163 and
otherwise complied with the requirements of Rule 163,
including without limitation the legending requirement, to qualify
such offer for the exemption from Section 5(c) of the Act provided
by Rule 163.
At
the respective times the Original Registration Statement, any
Registration Statement and any amendment thereto became effective,
at the deemed effective date with
- 3 -
respect to the
Underwriters pursuant to Rule 430B(f)(2) of the Securities Act
Regulations, at the date of this Agreement and at each relevant
Closing Date, the Registration Statement and any amendments or
supplements thereto complied and will comply, in all material
respects with the requirements of the Act and the Securities Act
Regulations and did not and will not contain an untrue statement of
a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not
misleading; the Prospectus and any further amendments or
supplements thereto, at the time the Prospectus or such amendment
or supplement was issued, at the date hereof, at the time of filing
pursuant to Rule 424(b) and at each relevant Closing Date, complied
and will comply, in all material respects with the requirements of
the Act and the Securities Act Regulations and did not, and any
amendment thereto will not, contain an untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; and each preliminary prospectus and the prospectus
filed as part of the Original Registration Statement as originally
filed or as part of any amendment or supplement thereto or filed
pursuant to Rule 424 of the Securities Act Regulations,
complied when so filed in all material respects with the Act and
the Securities Act Regulations;
(3)
As of the Applicable Time (as defined below) and each Closing Date,
neither (x) the Issuer General Use Free Writing Prospectus(es)
(as defined below) identified on Schedule IV hereto, the
Statutory Prospectus (as defined below), all considered together
(collectively, the “ General Disclosure Package
”), nor (y) any individual Issuer Limited Use Free
Writing Prospectus (as defined below), when considered together
with the General Disclosure Package, included any untrue statement
of a material fact or omitted to state any material fact necessary
in order to make the statements therein, in the light of the
circumstances under which they were made, not
misleading.
As used in this
subsection and elsewhere in this Agreement:
“
Applicable Time ” means 8:45 a.m. (Eastern time) on
May 13, 2009 or such other time as agreed by the Company and
the Representatives.
“ Issuer
Free Writing Prospectus ” means any “issuer free
writing prospectus,” as defined in Rule 433 of the
Securities Act Regulations (“ Rule 433 ”),
relating to the Offered Securities that (i) is required to be
filed with the Commission by the Company, (ii) is a
“road show for an offering that is a written
communication” within the meaning of Rule 433(d)(8)(i),
whether or not required to be filed with the Commission or
(iii) is exempt from filing pursuant to Rule 433(d)(5)(i)
because it contains a description of the Offered Securities or of
the offering that does not reflect the final terms, in each case in
the form filed or required to be filed with the Commission or, if
not required to be filed, in the form retained in the
Company’s records pursuant to Rule 433(g).
“ Issuer
General Use Free Writing Prospectus ” means any Issuer
Free Writing Prospectus that is intended for general distribution
to prospective investors .
- 4 -
“ Issuer
Limited Use Free Writing Prospectus ” means any Issuer
Free Writing Prospectus that is not an Issuer General Use Free
Writing Prospectus.
“
Statutory Prospectus ” as of any time means the base
prospectus relating to the Offered Securities that is included in
the Registration Statement immediately prior to that time,
including any document incorporated by reference therein and the
preliminary prospectus supplement relating to the Offered
Securities immediately prior to such time.
As of the time of
the filing of the Final Term Sheet (as defined in
Section 4.C), the General Disclosure Package, when considered
together with the Final Term Sheet, will not include any untrue
statement of a material fact or omit to state any material fact
necessary in order to make the statements therein, in the light of
the circumstances under which they are made, not
misleading.
Each Issuer Free
Writing Prospectus, as of its issue date and at all subsequent
times through the completion of the public offer and sale of the
Offered Securities or until any earlier date that the issuer
notified or notifies the Representatives as described in
Section 4.C, did not, does not and will not include any
information that conflicted, conflicts or will conflict with the
information contained in the Registration Statement or the
Prospectus, including any document incorporated by reference
therein and any preliminary or other prospectus deemed to be a part
thereof that has not been superseded or modified.
The
representations and warranties in Section 1.A(2) and
(3) of this Agreement shall not apply to statements in or
omissions from the Registration Statement, the Prospectus or any
Issuer Free Writing Prospectus made in reliance upon and in
conformity with written information furnished to the Company by any
Underwriter through the Representatives expressly for use
therein.
(4)
Each Prospectus and preliminary prospectus delivered to the
Underwriters and used in connection with this offering was
identical to the electronically transmitted copies thereof filed
with the Commission pursuant to EDGAR, except to the extent
permitted by Regulation S-T under the Act.
B. No
Stop Order . No stop order suspending the effectiveness of the
Registration Statement or any part thereof has been issued and no
proceeding for that purpose has been instituted or, to the
knowledge of either of the Transaction Entities, threatened by the
Commission or by the state securities authority of any
jurisdiction. No order preventing or suspending the use of the
Prospectus has been issued, and no proceeding for that purpose has
been instituted or, to the knowledge of either of the Transaction
Entities, threatened by the Commission or by the state securities
authority of any jurisdiction.
C.
Incorporated Documents . Each document incorporated or
deemed to be incorporated by reference in the Prospectus, the
Registration Statement or the General Disclosure Package (the
“ Incorporated Documents ”), when such
Incorporated Document was filed with the Commission, complied in
all material respects with the requirements of the Act and the
Securities Act Regulations or the Exchange Act and the rules and
regulations of the Commission
- 5 -
thereunder (the
“ Exchange Act Regulations ”), as applicable, in
effect at the time of the filing, and, when read together with the
other information in the Prospectus, (i) at the time the
Original Registration Statement became effective, (ii) at the
earlier of the time the Prospectus was first used and the date and
time of the first contract of sale of Offered Securities in this
offering, and (iii) at each Closing Date, each such
Incorporated Document did not or will not, as the case may be,
contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which
they were made, not misleading.
D.
Company Formation; Good Standing; Qualification . The
Company has been duly formed and is validly existing as a
corporation in good standing under the laws of the state of
Maryland, with power and authority (corporate and other) to own its
properties and conduct its business as described in the Prospectus
and to enter into and perform its obligations under this Agreement
and as general partner of the Operating Partnership to cause the
Operating Partnership to enter into and perform the Operating
Partnership’s obligations under this Agreement, and the
Company is duly qualified to do business as a foreign corporation
in good standing in all other jurisdictions in which its ownership
or lease of property or the conduct of its business requires such
qualification, except where the failure to so qualify would not
reasonably be expected to have, individually or in the aggregate, a
material adverse effect on the condition (financial or other),
business, earnings, properties, assets, results of operations or
prospects of the Transaction Entities and the Subsidiaries (as
defined below) taken as a whole, whether or not in the ordinary
course (“ Material Adverse Effect ”).
E.
Operating Partnership Formation; Good Standing; Qualification;
Interests in Operating Partnership . The Operating Partnership
has been duly formed and is validly existing as a limited
partnership in good standing under the laws of the state of
Maryland, is duly qualified to do business and is in good standing
as a foreign limited partnership in each jurisdiction in which its
ownership or lease of property or the conduct of its business
requires such qualification, except where the failure to so qualify
would not reasonably be expected to have a Material Adverse Effect,
and has all power and authority necessary to own its properties and
conduct its business as described in the Prospectus and to enter
into and perform its obligations under this Agreement. The Company
is the sole general partner of the Operating Partnership and holds
the number and/or percentage of OP Units as disclosed in or
incorporated by reference in the Prospectus, as of the dates set
forth therein, free and clear of any security interests, liens,
mortgages, encumbrances, pledges, claims, defects or other
restrictions of any kind (collectively, “ Liens
”). The Fourth Amended and Restated Agreement of Limited
Partnership of the Operating Partnership, as amended (the “
Operating Partnership Agreement ”) is in full force
and effect. The aggregate percentage interests of the Company and
the limited partners in the Operating Partnership are as set forth
in or incorporated by reference in the Prospectus, as of the dates
set forth therein; provided, that to the extent any portion of the
over-allotment option described in Section 2 hereof is
exercised at any Optional Closing Date, the percentage interest of
the Company and of such limited partners in the Operating
Partnership will be adjusted accordingly.
F.
Subsidiary Formation; Good Standing; Qualification; Liens;
Pre-Emptive Rights . Each direct or indirect subsidiary of the
Company and of the Operating Partnership, all of which are listed
on Schedule II hereto (each, a “
Subsidiary ” and together the “
Subsidiaries ”),
- 6 -
has been duly
formed and is validly existing as a corporation, limited
partnership, limited liability company or common law trust, as the
case may be, in good standing under the laws of the jurisdiction of
its organization, with power and authority (corporate and other) to
own its assets and conduct its business as described in the
Prospectus and to enter into and to perform its obligations under
this Agreement; and is duly qualified to do business as a foreign
corporation, limited partnership or limited liability company, as
the case may be, in good standing in all other jurisdictions in
which its ownership or lease of property or the conduct of its
business requires such qualification, except where the failure to
so qualify would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect; all of its issued
and outstanding capital stock or other ownership interests have
been duly authorized and validly issued and are fully paid and
non-assessable; and all outstanding shares of its capital stock or
other ownership interests are owned by the Company or the Operating
Partnership, directly or through the Subsidiaries, free and clear
of any Liens, except as described in the Prospectus or where such
Liens would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect. None of the equity
interests of any Subsidiary were issued in violation of the
preemptive or other similar rights of any securityholder of such
Subsidiary. There are no outstanding options, rights (preemptive or
otherwise) or warrants to purchase or subscribe for equity
interests or other securities of any Subsidiary, except as set
forth in the organizational documents of such
Subsidiary.
G.
Capital of the Company; Options; No Preemptive Rights . The
authorized, issued and outstanding capital stock of the Company is
in all material respects as set forth in the Prospectus in the
column entitled “Historical Consolidated,” including
the footnotes thereto, under the caption
“Capitalization.” None of the outstanding shares of
capital stock of the Company was issued in violation of the
preemptive or other similar rights of any securityholder of the
Company. Further, (i) except for shares of Common Stock
reserved for issuance (A) upon exchange or redemption of the
OP Units or long term incentive plan units of the Operating
partnership (the “ LTIP Units ”), (B) in
connection with the existing BioMed Realty Trust, Inc. and BioMed
Realty, L.P. 2004 Incentive Award Plan, including any amendment
proposed in the Company’s 2009 proxy statement and approved
at the Company’s 2009 Annual Meeting of Stockholders (the
“ Equity Incentive Plan ”), or (C) upon
exchange of the Operating Partnership’s 4.50% Exchangeable
Senior Notes due 2026 (the “ Exchangeable Notes
”), all as disclosed in the Prospectus, no shares of Common
Stock are reserved for any purpose; (ii) except for the OP
Units, LTIP Units and the Exchangeable Notes as disclosed in the
Prospectus, there are no outstanding securities convertible into or
exchangeable for any shares of Common Stock; and (iii) except
for the Exchangeable Notes disclosed in the Prospectus and in
connection with our investment in one of our joint ventures,
pursuant to which the joint venture party has the right to require
the Operating Partnership to issue OP Units in connection with a
put call option, which represents less than 1% of the
Company’s currently outstanding Common Stock, there are no
outstanding options, rights (preemptive or otherwise) or warrants
to purchase or subscribe for shares of Common Stock or any other
securities of the Company or of the Operating
Partnership.
H.
Authorization of Issuance of Offered Securities; Conformity with
Applicable Laws . The Offered Securities and all other
outstanding shares of capital stock of the Company have been duly
authorized; all outstanding shares of capital stock of the Company
are, and, when the Offered Securities have been delivered and paid
for in accordance with this Agreement on each Closing Date, such
Offered Securities will have been, validly issued, fully paid and
non-
- 7 -
assessable,
have been, or will be, offered and sold in compliance with all
applicable federal and state securities laws and will conform in
all material respects to the description thereof contained in the
Prospectus. Upon payment of the purchase price and delivery of the
Offered Securities in accordance herewith, the Underwriters will
receive good valid and marketable title to the Offered Securities,
free and clear of all Liens. The form of the certificates to be
used to evidence the Offered Securities will be in substantially
the form filed or incorporated by reference as an exhibit to the
Registration Statement, is in due and proper form and complies with
all applicable legal requirements, the requirements of the charter
and bylaws of the Company and the requirements of the New York
Stock Exchange, Inc. (the “ NYSE ”).
I.
Authorization of Issuance of OP Units; Conformity with
Applicable Laws; No Preemptive Rights . The issued and
outstanding OP Units and Series A preferred units of limited
partnership interest in the Operating Partnership have been duly
authorized for issuance by the Operating Partnership to the holders
thereof and are validly issued, fully paid and non-assessable, have
been offered and sold or exchanged by the Operating Partnership in
compliance with applicable laws and conform in all material
respects to the description thereof contained in the Prospectus.
The OP Units to be issued to the Company in connection with the
offering contemplated by this Agreement have been duly authorized
for issuance by the Operating Partnership and, when issued and
delivered by the Operating Partnership to the Company in connection
with the contribution of the net proceeds of the offering, will be
validly issued, fully paid and non-assessable. The OP Units will be
exempt from registration or qualification under the Act and
applicable state securities laws. None of the OP Units will be
subject to or issued in violation of the preemptive or other
similar rights of any securityholder of the Operating
Partnership.
J. No
Other Brokerage Fees . Except as disclosed in the Prospectus,
there are no contracts, agreements or understandings between the
Transaction Entities, any Subsidiary and any person that would give
rise to a valid claim against the Transaction Entities, any
Subsidiary, or any Underwriter for a brokerage commission,
finder’s fee or other like payment in connection with this
offering.
K. No
Registration Rights . Except for the Registration Rights
Agreements entered into in connection with the Company’s
initial public offering by and among the Company, the Operating
Partnership and the holders of OP Units party thereto dated as of
August 13, 2004, as amended (the “ Unitholder
Registration Rights Agreements ”), the Registration
Rights Agreement entered into in connection with the issuance of
the Exchangeable Notes by and among the Company and the initial
purchasers of the Exchangeable Notes dated as of September 25,
2006 (the “ Notes Registration Rights Agreement
”) and the Registration Rights Agreement entered into in
connection with the formation of BMR-PR II LLC by and between the
Company and the Prudential Insurance Company of America dated as of
April 4, 2007 (the “ JV Registration Rights
Agreement ”), there are no contracts, agreements or
understandings between the Transaction Entities and any person
granting such person the right to require the Transaction Entities
to file a registration statement under the Act with respect to any
securities of the Transaction Entities owned or to be owned by such
person. There are no contracts, agreements or understandings
between the Transaction Entities and any person granting such
person the right to require the Transaction Entities to include
such securities in the securities registered pursuant to the
Registration Statement.
- 8 -
L. No
Violations or Defaults . None of the Transaction Entities nor
the Subsidiaries, (i) is in violation of its charter or
by-laws or other similar organizational documents, (ii) is in
default (whether with or without the giving of notice or passage of
time or both) in the performance or observance of any obligation,
agreement, term, covenant or condition contained in a contract,
indenture, mortgage, deed of trust, loan or credit agreement, note,
lease (under which such Transaction Entity or a Subsidiary is
landlord or otherwise), ground lease or air space lease (under
which such Transaction Entity or a Subsidiary is tenant),
development agreement, reciprocal easement agreement, deed
restriction, hotel management agreement, parking management
agreements, or other agreement or instrument to which it is a party
or by which it or any of them is a party or may be bound, or to
which any of the Properties (as hereinafter defined) or any of its
property or assets of such Transaction Entity or Subsidiary is
subject (collectively, “ Agreements or Instruments
”), or (iii) is in violation of any law, ordinance,
governmental rule, regulation or court decree to which it or the
Properties or any of its other properties or assets may be subject,
except for such defaults or violations that would not have,
individually or in the aggregate, a Material Adverse
Effect.
M. No
Consents Required . No consent, approval, authorization, or
order of, or filing or registration with, any governmental agency
or body or any court or any third party is required for the
consummation of the transactions contemplated by this Agreement,
except as have been obtained or made under the Act and as may be
required under state securities laws or the rules of The Financial
Industry Regulatory Authority (“ FINRA ”) or
that the absence of which would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse
Effect.
N.
Non-Contravention . Except as disclosed in the Prospectus,
the execution, delivery and performance of this Agreement by the
Transaction Entities and the consummation of the transactions
contemplated hereby (including the issuance and sale of the Offered
Securities and the use of the proceeds from the sale of the Offered
Securities as described in the Prospectus under “Use of
Proceeds”) do not and will not (whether with or without the
giving of notice or passage of time or both) conflict with or
result in a breach or violation of any of the terms and provisions
of, or constitute a default (or give rise to any right of
termination, acceleration, cancellation, repurchase or redemption)
or Repayment Event (as hereinafter defined) under, or result in the
creation or imposition of a Lien upon any property or assets of the
Transaction Entities or any Subsidiary pursuant to, (i) any
statute, any rule, regulation or order of any governmental agency
or body or any court, domestic or foreign, having jurisdiction over
the Transaction Entities or any of the Subsidiaries or any of their
properties, assets or business currently owned by them; (ii) any
term, condition or provision of any Agreements or Instruments; or
(iii) the charters, by-laws or other organizational documents,
as applicable, of the Transaction Entities or any of the
Subsidiaries, except for such conflicts, breaches, violations or
defaults that (with respect to subclauses (i) and
(ii) above) would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. As
used herein, “ Repayment Event ” means any event
or condition which, without regard to compliance with any notice or
other procedural requirements, gives the holder of any note,
debenture or other evidence of indebtedness (or any person acting
on such holder’s behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by
the Company, the Operating Partnership or any
Subsidiary.
- 9 -
O.
Validity and Sufficiency of Agreements . This Agreement has
been duly and validly authorized, executed and delivered by each of
the Transaction Entities party thereto and, to the knowledge of the
Transaction Entities, the Lock-Up Agreements have been duly and
validly authorized, executed and delivered by each other party
thereto, and the Operating Partnership Agreement is a valid and
binding agreement of each of the Transaction Entities that are
parties thereto, enforceable against such Transaction Entity (and,
to the knowledge of the Transaction Entities, against each other
party thereto with respect to the Lock-Up Agreements) in accordance
with its terms, except (i) to the extent that such
enforceability may be limited by applicable bankruptcy, insolvency,
fraudulent transfer, moratorium, reorganization or other similar
laws now or hereafter in effect relating to or affecting
creditors’ rights; (ii) as limited by the effect of
general principles of equity, whether enforcement is considered in
a proceeding in equity or at law (including the possible
unavailability of specific performance or injunctive relief),
concepts of materiality, reasonableness, good faith and fair
dealing, and the discretion of the court before which any
proceeding therefore may be brought; (iii) the
unenforceability under certain circumstances under law or court
decisions of provisions providing for the indemnification of or
contribution to a party with respect to a liability where such
indemnification or contribution is contrary to public policy; and
(iv) the unenforceability of any provision requiring the
payment of attorney’s fees, except to the extent that a court
determines such fees to be reasonable. For purposes of this
Agreement, “ Lock-Up Agreements ” shall mean at
the First Closing Date, the lock up agreements in the form attached
hereto as Exhibit A by each of the persons listed on
Schedule III hereto.
P.
Licenses . The Transaction Entities and the Subsidiaries
possess adequate certificates, authorities, licenses, consents,
approvals, permits and other authorizations (“
Licenses ”) issued by appropriate governmental
agencies or bodies or third parties necessary to conduct the
business now operated by them, have maintained such Licenses in
full force and effect, and have not received any notice of
proceedings relating to the revocation or modification of any such
Licenses that, if determined adversely to the Transaction Entities
or any of the Subsidiaries, would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. The
Transaction Entities and the Subsidiaries are in compliance with
the terms and conditions of all such Licenses except as would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect.
Q.
Financial Statements . The financial statements included in
or incorporated by reference into the Registration Statement, the
Prospectus and the General Disclosure Package, together with the
related schedules and notes, present fairly (1) the financial
position of the Company and its consolidated Subsidiaries (and the
combined financial position of any predecessor entities) at the
dates indicated; and (2) the results of operations,
stockholders’ equity and cash flows of the Company and its
consolidated Subsidiaries (and the combined results of operations,
stockholders’ equity, and cash flows of any predecessor
entities) for the periods specified; said financial statements have
been prepared in conformity with U.S. generally accepted accounting
principles (“ GAAP ”) applied on a consistent
basis throughout the periods involved; said financial statements
have been prepared on a consistent basis with the books and records
of the Company and its consolidated Subsidiaries (and any
predecessor entities) in the case of the statements of financial
position of the Company and its consolidated Subsidiaries (and the
combined financial position of any predecessor entities) and the
results of operations, stockholders’ equity and cash flows of
the Company and its consolidated Subsidiaries (and the
- 10 -
combined
results of operations, stockholders’ equity, and cash flows
of any predecessor entities). The supporting schedules incorporated
by reference into the Registration Statement, the Prospectus and
General Disclosure Package present fairly in accordance with GAAP
the information required to be stated therein. All non-GAAP
financial measures included in or incorporated by reference into
the Registration Statement, the Prospectus and the General
Disclosure Package comply with the requirements of
Regulation G and Item 10 of Regulation S-K under the
Act to the extent such rules are applicable to such financial
statements. Other than the historical financial statements, and
schedules relating thereto included in or incorporated by reference
into the Registration Statement, the Prospectus and the General
Disclosure Package, no other historical or pro forma financial
statements (or schedules) are required by the Act or the Securities
Act Regulations to be included therein or in any document required
to be filed with the Commission under the Exchange Act or the
Exchange Act Regulations.
R.
Independent Registered Public Accounting Firm . The
accountants who certified the financial statements and supporting
schedules included in or incorporated by reference into the
Registration Statement and delivered the initial letter referred to
in Section 5.A hereof, are an independent registered
public accounting firm as required by the Act, the Securities Act
Regulations, the Exchange Act, the Exchange Act Regulations, and
the Public Company Accounting Oversight Board (United
States).
S. REIT
Status . Commencing with the taxable year ending
December 31, 2004, the Company has been and is organized and
operated in conformity with the requirements for qualification and
taxation as a real estate investment trust (a “ REIT
”) under the Internal Revenue Code 1986, as amended (the
“ Code ”).
T. Tax
Returns and Matters . The Transaction Entities and each of the
Subsidiaries (including any predecessor entities) have filed all
foreign, federal, state and local tax returns that are required to
be filed or have requested extensions thereof (except in any case
in which the failure so to file would not reasonably be expected to
have a Material Adverse Effect) and have paid all taxes required to
be paid by them and any other assessment, fine or penalty levied
against them, to the extent that any of the foregoing is due and
payable, except for any such assessment, fine or penalty that
(i) would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect or (ii) as
described in or contemplated by the Prospectus. Except as disclosed
in the Prospectus, there is no pending or, to the knowledge of the
Transaction Entities, threatened special assessment, tax reduction
proceeding or other action which could increase or decrease the
real property taxes or assessments of any Property, which would
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect.
U. No
Other Offering Documents or Prospectuses . The Transaction
Entities and each of the Subsidiaries have not distributed, and
prior to the later of the First Closing Date and the completion of
the distribution of the Offered Securities, will not distribute,
any offering material in connection with the offering or sale of
the Offered Securities other than the Registration Statement, the
Prospectus, the General Disclosure Package or any other materials,
if any, permitted by the Act (which were disclosed to the
Representatives and their counsel).
- 11 -
(1) Each
Transaction Entity is in compliance, in all material respects, with
all presently applicable provisions of the Employee Retirement
Income Security Act of 1974, as amended, including the regulations
and published interpretations thereunder (“ ERISA
”); no “reportable event” (as defined in ERISA
other than an event for which the notice requirements have been
waived by regulations) has occurred with respect to any
“pension plan” (as defined in ERISA) for which any
Transaction Entity would have any liability; no Transaction Entity
has incurred or expects to incur liability under (i) Title IV
of ERISA with respect to termination of, or withdrawal from, any
“pension plan” or (ii) Sections 412 or 4971
of the Code including the regulations and published interpretations
thereunder; and each “pension plan” for which any
Transaction Entity would have any liability that is intended to be
qualified under Section 401(a) of the Code has received a favorable
determination letter from the Internal Revenue Service that such
plan is so qualified in all material respects and, except to the
knowledge of the Transaction Entities, nothing has occurred,
whether by action or by failure to act, which would cause the loss
of such qualification, except where such non-compliance, reportable
events, liabilities or failure to be so qualified would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect.
(2) The assets of
the Transactions Entities and the Subsidiaries do not constitute
“plan assets” of an ERISA regulated employee benefit
plan.
(3) The Company is
a “real estate operating company” as such term is
defined in paragraph (e) of the plan assets regulation in 29
C.F.R. Section 2510.3-101, or will be an “operating
company” as defined in the first sentence of paragraph
(c) thereof.
(1) The
Transaction Entities or the Subsidiaries have good and marketable
title (either in fee simple or pursuant to a leasehold interest) to
all of the properties owned or leased by them (the “
Properties ”), in each case, free and clear of all
Liens except such as (i) are disclosed in the Prospectus; or
(ii) would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect. Any real property,
improvements, equipment and personal property held under lease by
the Company or any Subsidiary are held under valid, existing and
enforceable leases which are in full force and effect, and none of
the Company, Operating Partnership nor any Subsidiary or, to any
Transaction Entity’s knowledge, any other party, is in
default under any such lease, with such exceptions as are disclosed
in the Prospectus or would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse
Effect;
(2) All of the
leases and subleases under which the Company, Operating Partnership
or any Subsidiary lease any portion of the Properties are in full
force and effect; there are no uncured events of default, or events
that with the giving of notice or passage of time, or both, would
constitute an event of default, by any Transaction Entity nor any
tenant under any of the terms and provisions of the leases
described above; and none of the Company, Operating Partnership nor
any Subsidiary has received any notice of any claim asserted by
anyone adverse to the rights of the Company, Operating Partnership
or Subsidiary under any of the leases or questioning or affecting
the rights of
- 12 -
the tenant of
the continued possession of the leased or subleased premises under
any such lease or sublease, in each case other than those that
would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect or that have been, in the
reasonable judgment of the Company, adequately reserved for in the
Company’s consolidated financial statements. No tenant which
has been specifically identified in the Prospectus under any of the
leases at the Properties has a right of first refusal or other
right or option to purchase the premises demised under such lease,
other than those which are disclosed in the Prospectus or with
respect to properties the value of which are not material to the
Transaction Entities and the Subsidiaries as a whole;
(3) Except as
disclosed in the Prospectus, none of the Transaction Entities, nor
any Subsidiary, knows of any violation of any municipal, state or
federal law, rule or regulation (including those pertaining to
environmental matters) concerning the Properties or any part
thereof which would reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect;
(4) Each of the
Properties complies with all applicable zoning laws, ordinances,
regulations, and deed restrictions or other covenants in all
material respects and, if and to the extent there is a failure to
comply, such failure would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse
Effect;
(5) None of the
Transaction Entities, nor any Subsidiary, has received from any
governmental authority any written notice of any condemnation of or
zoning change affecting the Properties or any part thereof, and
none of the Transaction Entities nor any Subsidiary or predecessor
entity knows of any such condemnation or zoning change that is
threatened against any of the Properties and that, if consummated,
would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect;
(6) Each of the
Properties is free of material structural defects and all building
systems contained therein are in good working order in all material
respects, subject to ordinary wear and tear, except as would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, or, in each instance, the Company
maintains adequate reserves to effect reasonably required repairs,
maintenance and capital expenditures; and
(7) Water,
stormwater, sanitary sewer, electricity and telephone service are
all available at the property lines of each Property over duly
dedicated streets or perpetual easements of record benefiting the
applicable Property, except as would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse
Effect.
X. No
Participating Interests . The mortgages and deeds of trust
encumbering the Properties and assets described in the Prospectus
are not convertible, and neither the Transaction Entities, any of
the Subsidiaries, nor any person affiliated therewith holds a
participating interest therein, and such mortgages and deeds of
trust are not cross-defaulted or cross-collateralized to any
property not owned directly or indirectly by the Transaction
Entities or any of the Subsidiaries.
- 13 -
Y.
Insurance . The Operating Partnership and any Subsidiary
that owns, or leases under ground leases, real property has
obtained title insurance on the fee interests (or leasehold
interests) in each of the Properties and other insurance covering
such risks and in amounts that are commercially reasonable for the
assets owned by them, and in each case such title insurance and
other insurance is in full force and effect. Neither the
Transaction Entities nor any of the Subsidiaries has any reason to
believe that any of them will not be able to obtain or renew its
existing insurance coverage as and when required by the preceding
or as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its
business.
Z.
Environmental Matters . Except as otherwise disclosed in the
Prospectus or as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse
Effect,
(1) none of the
Transaction Entities, any of the Subsidiaries nor, to the best
knowledge of the Transaction Entities, any other owners of each
Property at any time or any other party has at any time handled,
stored, treated, transported, manufactured, transferred or
otherwise dealt with, Hazardous Materials (as hereinafter defined)
on, to or from the Properties, other than by any such action taken
in compliance with all applicable Environmental Laws in all
material respects;
(2) none of the
Transaction Entities, any of the Subsidiaries nor, to the best
knowledge of the Transaction Entities, any other owners of each
Property at any time or any other party has at any time spilled,
leaked, discharged, dumped, released, or otherwise disposed of
Hazardous Materials on, to or from the Properties, except where
such events would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect;
(3) the
Transaction Entities do not intend to use the Properties or any
subsequently acquired properties, or to lease the Properties or any
subsequently acquired properties to any party that will use such
Properties or any subsequently acquired properties, for the purpose
of handling, storing, treating, transporting, manufacturing,
transferring or otherwise dealing with Hazardous Materials other
than by any such action taken in compliance with all applicable
Environmental Laws;
(4) the
Transaction Entities do not intend to use the Properties or any
subsequently acquired properties, or to lease the Properties or any
subsequently acquired properties to any party that will use such
Properties or any subsequently acquired properties, for the purpose
of spilling, leaking, releasing, discharging, dumping, or otherwise
disposing of Hazardous Materials on or from such
Properties;
(5) none of the
Transaction Entities nor any of the Subsidiaries knows of any
seepage, leak, discharge, release, emission, spill, or dumping of
Hazardous Materials into soil or waters (including, but not limited
to, groundwater and surface water) on or adjacent to the Properties
or any other real property owned or occupied by any such party, or
onto lands from which Hazardous Materials might seep, flow or drain
into such
- 14 -
waters, except
where such events would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse
Effect;
(6) none of the
Transaction Entities nor any of the Subsidiaries has received any
notice of or is aware of any receipt by any other party of a notice
of, or has any knowledge of any occurrence or circumstance that
would give rise to a claim under or pursuant to any Environmental
Law, pertaining to Hazardous Materials on or originating from any
of the Properties or any assets described in the Prospectus (or,
the most recent preliminary prospectus) or any other real property
owned or occupied by any such party or arising out of the conduct
of any such party, including without limitation a claim under or
pursuant to any Environmental Law (as hereinafter
defined);
(7) none of the
Transaction Entities nor any of the Subsidiaries has (A) been
notified that it is potentially liable under or (B) received
any requests for information or other correspondence concerning any
site or facility under CERCLA or any similar law;
(8) none of the
Properties are included or, to the best of the Transaction
Entities’ knowledge, proposed for inclusion on the National
Priorities List issued pursuant to CERCLA (as hereinafter defined)
by the United States Environmental Protection Agency (the “
EPA ”) or, to the best of the Transaction
Entities’ knowledge, proposed for inclusion on any similar
list or inventory issued pursuant to any other Environmental Law or
issued by any other Governmental Authority (as hereinafter
defined);
(9) the
Transaction Entities do not intend to use the Properties or other
assets owned by the Transaction Entities or the Subsidiaries other
than in compliance with applicable Environmental Laws;
(10) to the best
knowledge of the Transaction Entities, the Properties contain no
above-ground and underground storage tanks, oil/water separators,
sumps, or septic systems; and
(11) (a) to
the best knowledge of the Transaction Entities, no building or
other improvement located on the Properties contains any asbestos
or asbestos-containing materials that would reasonably be expected
to have, individually or in the aggregate, a Material Adverse
Effect; (b) all asbestos or asbestos-containing materials are
managed, handled, treated, and removed in compliance with
Environmental Law, except where such noncompliance would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect; and (c) the Transaction Entities do
not intend to manage, handle, treat, or remove asbestos other than
in compliance with Environmental Law.
As used herein,
“ Hazardous Material ” means any chemical,
substance, waste, material, pollutant, contaminant, equipment or
fixture defined as or deemed hazardous or toxic or otherwise
regulated under any Environmental Law, including, without
limitation, RCRA hazardous wastes, CERCLA hazardous substances,
pesticides and other agricultural chemicals,
- 15 -
oil and
petroleum products or byproducts and any constituents thereof, urea
formaldehyde insulation, lead in paint or drinking water, asbestos,
and polychlorinated biphenyls (PCBs).
As used herein,
“ Environmental Laws ” means all codes, laws
(including, without limitation, common law), ordinances,
regulations, reporting or licensing requirements, rules, or
statutes in effect as of the Effective Date relating to pollution
or protection of human health or the environment (including ambient
air, surface water, ground water, land surface, or subsurface
strata), including, without limitation (i) the Comprehensive
Environmental Response Compensation and Liability Act, 42 U.S.C.
§§9601 et seq . (“ CERCLA ”);
(ii) the Solid Waste Disposal Act, as amended by the Resource
Conservation and Recovery Act, 42 U.S.C. §§6901 et seq.,
(“ RCRA ”); (iii) the Emergency Planning and
Community Right to Know Act (42 U.S.C. §§11001 et seq.);
(iv) the Clean Air Act (42 U.S.C. §§ 7401 et seq.);
(v) the Clean Water Act (33 U.S.C. §§1251 et seq.);
(vi) the Toxic Substances Control Act (15 U.S.C.
§§2601 et seq.); (vii) the Hazardous Materials
Transportation Act (49 U.S.C. §§ 5101 et seq.);
(viii) the Safe Drinking Water Act (41 U.S.C. §§300f
et seq.); (ix) any state, county, municipal or local statues,
laws or ordinances similar or analogous to the federal statutes
listed in parts (i) through (viii), inclusive, of this
subparagraph, (x) any amendments to the statutes, laws or
ordinances listed in parts (i) through (ix), inclusive of this
subparagraph, (xi) any rules, regulations, enforceable
guidelines or directives, orders or the like adopted pursuant to or
implementing the statutes, laws, ordinances and amendments listed
in parts (i) through (x), inclusive, of this subparagraph; and
(xii) any other law, statute, ordinance, amendment, rule,
regulation, guideline, directive, order or the like relating to
environmental, health or safety matters.
As used herein, a
“ Governmental Authority ” means any federal,
state, or local governmental authority having or claiming
jurisdiction over the properties and assets described in the
Prospectus.
AA.
Independence of Environmental Consultants . None of the
environmental consultants that prepared the Phase I and II
Environmental Audits with respect to any of the Properties was
employed for such purpose on a contingent basis or has any
substantial interest (contingent or otherwise) in the Transaction
Entities or any of the Subsidiaries (including any predecessor
entity), and none of them nor any of their directors, officers or
employees is connected with the Transaction Entities or any of the
Subsidiaries (or any of their predecessor entities) as a promoter,
selling agent, voting trustee, director, officer or
employee.
BB. NYSE
Listing Approval . Th
|